Common Drugs with Effective Off-Label Uses
Mohammed M. Alshehri, Mahmoud M. E. Mudawi
Journal of Pharmaceutical Research International · pp. 25–33 · Published 27 Jun 2020
10.9734/jpri/2020/v32i1030490Abstract
The term off-label drug use (OLDU) is utilized broadly in the medical literature. It is a polarizing term since it may be related to incredible advantage or harm to patients. OLDU is defined as drug uses that not included in the indications or dosage regimens listed in the drug labeling. The main issue with off-label use is that there is insufficient information supports the use of the drug so this review aims to give brief information about some common drugs with effective and useful off-label uses based on scientific study and to encourage the researcher to provide sufficient information for the physician and health care providers about off-label uses to decrease the risk of harm to the patients. There are many drugs with various off-label uses that play an important role clinically such as using atorvastatin in chronic heart failure (CHF) due to its pleiotropic action also it can show a significant reduction in the frequency of hospitalization due to CHF exacerbation. However, that make off-label uses an important is several diseases do not have approved drugs, partly because the diseases are rare or conducting clinical trials and marketing the drug for such diseases may not be gainful.
Cited by 6
ALSayyed A.N. Sallam, Derar M. Omari · Novel Formulations and Future Trends · 2024
N. N. Ngcobo, L. J. Mathibe · Orphanet Journal of Rare Diseases · 2024
Showing 2 of 6 known citations — external sources report more than can currently be individually listed.
Related research
- The Effect of Two Types of Statins (Rosuvastatin and Atorvastatin) on the Fertility of Male and Female Mice — shares topic coverage
- Biochemical and Toxicological Evaluation of Atorvastatin and Riboflavin in Diethylnitrosamine Induced Hepatocellular Carcinoma — shares topic coverage
- Role of Magnesium Supplement on Hyperlipidemia and L-CAT Level in Patient on Atorvastatin Therapy — shares topic coverage
- Improve Markers of Oxidative Stress and Coagulation Parameters in Response to Atorvastatin Therapy — shares topic coverage
- Role of Bromelain Loaded Silver Nanoparticles in the Treatment of Induced Hyperlipidemia in Male Albino Rats — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
6
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.